Condition: Menopause · Estrogen Deficiency · Sponsor: Margan Biotech
This is a prospective, multicenter, observational clinical study conducted under routine clinical practice conditions aimed at describing adherence to a creatine-based nutritional supplement (Creaticare FEM) in estrogen-depleted adult women. Participants will receive the supplement for 12 weeks, and adherence will be assessed as the percentage of doses consumed and the proportion of participants achieving ≥80% adherence. Secondary outcomes include persistence, satisfaction, tolerability, and adherence to recommended physical activity. Exploratory outcomes include changes in muscle strength, body composition, quality of life, joint pain, and skin health.
This description comes directly from the study's public registry record.
Silvia Martinez · +34606441146 · silvia.martinez@marganbiotech.com
Always discuss trial participation with your own doctor first.
| Clínica Palacios | Madrid, Madrid, Spain | Recruiting |
| Menoclinica by Palacios | Madrid, Madrid, Spain | Recruiting |
| Ginegetafe | Madrid, Madrid, Spain | Recruiting |
| Clinica Palacios Málaga | Málaga, Málaga, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07580846